$279.79
1.19% yesterday
NYSE, Nov 20, 10:00 pm CET

Penumbra, Inc. Stock price

$279.79
+32.17 12.99% 1M
-1.34 0.48% 6M
+42.31 17.82% YTD
+40.59 16.97% 1Y
+87.37 45.41% 3Y
+20.64 7.96% 5Y
+233.81 508.50% 10Y
+238.49 577.46% 20Y
NYSE, Closing price Thu, Nov 20 2025
-3.36 1.19%

New AI Insights on Penumbra, Inc. Insights AI Insights on Penumbra, Inc.

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?

Key metrics

Basic
Market capitalization
$11.0b
Enterprise Value
$10.5b
Net debt
positive
Cash
$470.3m
Shares outstanding
39.2m
Valuation (TTM | estimate)
P/E
67.1 | 74.1
P/S
8.2 | 7.9
EV/Sales
7.9 | 7.6
EV/FCF
68.9
P/B
8.1
Financial Health
Equity Ratio
75.1%
Return on Equity
1.2%
ROCE
11.0%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$1.3b | $1.4b
EBITDA
$173.2m | $236.9m
EBIT
$172.8m | $184.1m
Net Income
$164.0m | $147.8m
Free Cash Flow
$152.6m
Growth (TTM | estimate)
Revenue
14.6% | 15.5%
EBITDA
45.1% | 159.2%
EBIT
54.5% | 113.5%
Net Income
374.8% | 955.0%
Free Cash Flow
13.7%
Margin (TTM | estimate)
Gross
66.8%
EBITDA
13.0% | 17.2%
EBIT
13.0%
Net
12.3% | 10.7%
Free Cash Flow
11.4%
More
EPS
$4.2
FCF per Share
$3.9
Short interest
6.5%
Employees
5k
Rev per Employee
$270.0k
Show more

Is Penumbra, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.

Penumbra, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Penumbra, Inc. forecast:

20x Buy
83%
4x Hold
17%

Analyst Opinions

24 Analysts have issued a Penumbra, Inc. forecast:

Buy
83%
Hold
17%

Financial data from Penumbra, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,334 1,334
15% 15%
100%
- Direct Costs 443 443
11% 11%
33%
891 891
17% 17%
67%
- Selling and Administrative Expenses 630 630
15% 15%
47%
- Research and Development Expense 88 88
9% 9%
7%
173 173
45% 45%
13%
- Depreciation and Amortization 0.44 0.44
94% 94%
0%
EBIT (Operating Income) EBIT 173 173
55% 55%
13%
Net Profit 164 164
375% 375%
12%

In millions USD.

Don't miss a Thing! We will send you all news about Penumbra, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Penumbra, Inc. Stock News

Neutral
PRNewsWire
one day ago
ALAMEDA, Calif. , Nov. 19, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025.
Positive
Investors Business Daily
15 days ago
Penumbra stock skyrocketed Thursday after the medtech company beat third-quarter expectations on the back of its blood-clot-removing tech.
Neutral
Seeking Alpha
15 days ago
Penumbra, Inc. ( PEN ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Cecilia Furlong Adam Elsesser - Co-Founder, Chairman & CEO Shruthi Narayan - President Maggie Yuen - Chief Financial Officer Conference Call Participants Travis Steed - BofA Securities, Research Division Robert Marcus - JPMorgan Chase & Co, Research Division Larry Biegelsen - Wells Fargo Securities, L...
More Penumbra, Inc. News

Company Profile

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products. Its target markets include interventional neuroradiologists, neurosurgeons, and interventional neurologists; and interventional radiologists, vascular surgeons, and interventional cardiologists. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.

Head office United States
CEO Adam Elsesser
Employees 4,500
Founded 2004
Website www.penumbrainc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today